Loading...
Publication: Ivermectin for treatment of COVID-19: Evidence review of clinical benefits and harms
Blockman, M Cohen, K De Waal, R Gray, A Kredo, T Maartens, G Nel, J Parrish, A Rees, H Reubenson, G
Blockman, M
Cohen, K
De Waal, R
Gray, A
Kredo, T
Maartens, G
Nel, J
Parrish, A
Rees, H
Reubenson, G
Citations
Altmetric:
Abstract
Description
Ivermectin is an antiparasitic drug that is commonly used for the treatment and prophylaxis of onchocerciasis and treatment of strongyloidiasis and intractable scabies. Ivermectin is not approved, globally, as an antiviral agent.
Date
2021-01-25
Journal Title
Journal ISSN
Volume Title
Publisher
South African National Department of Health
Collections
Research Projects
Organizational Units
Journal Issue
Keywords
Ivermectin,COVID-19,SARS-CoV-2,Systematic review,Rapid review,Therapy,Remedy,Treatment